Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Inovio’s reinvention falls flat
Inovio’s reinvention falls flat
EP Vantage
Inovio
VGX-3100
cancer vaccines
cancer
Flag link:
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Fierce Biotech
Xilio Therapeutics
funding
immunotherapy
clinical trials
cancer
oncology
Yervoy
Flag link:
An mRNA vaccine delivered in hydrogel shows promise as a durable cancer immunotherapy
An mRNA vaccine delivered in hydrogel shows promise as a durable cancer immunotherapy
Fierce Biotech
MRNA
vaccines
hydrogels
cancer
Flag link:
Novartis’s canakinumab cancer test approaches
Novartis’s canakinumab cancer test approaches
EP Vantage
Novartis
Regeneron
canakinumab
cancer
non-small cell lung cancer
Flag link:
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Fierce Biotech
Roche
earnings
cancer
autoimmune disease
drug development
Flag link:
Amgen slams the brakes on a clutch of cancer drugs as reality BiTEs
Amgen slams the brakes on a clutch of cancer drugs as reality BiTEs
Fierce Biotech
Amgen
earnings
cancer
oncology
drug development
Flag link:
Why Cardiff Oncology Ran Up 1,350% in 2020
Why Cardiff Oncology Ran Up 1,350% in 2020
Motley Fool
Cardifff Oncology
oncology
cancer
KRAS mutation
Flag link:
Amgen study data bolster prospects of KRAS-blocking cancer drug
Amgen study data bolster prospects of KRAS-blocking cancer drug
BioPharma Dive
Amgen
sotorasib
clinical trials
KRAS mutation
cancer
Flag link:
Go or no go? Oncology decisions ahead for the FDA
Go or no go? Oncology decisions ahead for the FDA
EP Vantage
FDA
cancer
oncology
Bristol-Myers Squibb
TG Therapeutics
Mallinckrodt
Sanofi
Regeneron
Sarepta Therapeutics
GSK
Oncopeptide
Flag link:
3 Blockbuster Drug Launches to Watch This Year
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Flag link:
Tracking cancer metastasis with CRISPR opens new areas for drug development
Tracking cancer metastasis with CRISPR opens new areas for drug development
Fierce Biotech
cancer
metastasis
CRISPR
R&D
Flag link:
Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
BioSpace
cancer
oncology
Kura Oncology
personalized medicine
Flag link:
The Future of Cancer Treatment Lies in Vaccines, Say These Pioneers
The Future of Cancer Treatment Lies in Vaccines, Say These Pioneers
BioSpace
cancer
oncology
vaccines
cancer vaccines
Neuvogen
Lineage Therapeutics
BioNTech
Flag link:
Dana-Farber launches venture fund targeting incurable cancers
Dana-Farber launches venture fund targeting incurable cancers
BioPharma Dive
Dana-Farber
cancer
venture capital
funding
Flag link:
Two Cancer Companies Close Series A Rounds Netting $144 Million
Two Cancer Companies Close Series A Rounds Netting $144 Million
BioSpace
cancer
oncology
funding
Delfi Diagnostics
Elucida Oncology
Flag link:
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies
Fierce Biotech
JPMHC 2021
Boehringer Ingelheim
Enara Bio
dark antigens
cancer
cancer vaccines
Flag link:
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Novartis
BeiGene
tiselizumab
cancer
drug development
Flag link:
AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs
AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs
Forbes
Valo Health
drug discovery
cancer
artificial intelligence
Flag link:
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
BioSpace
funding
biotech
IconOVir Bio
oncolytic viruses
cancer
oncology
Aro Biotherapeutics
RNA
Flag link:
Ikena bags $120M to advance growing pipeline of cancer drugs
Ikena bags $120M to advance growing pipeline of cancer drugs
Fierce Biotech
Ikena Oncology
cancer
oncology
funding
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »